The Penicillins and Streptomycins dosage market in the Czech Republic experienced a declining trend from 2013 to 2023, with the market size value per capita decreasing from $8.69 to $5.63. In 2023, the market stood at $5.63, reflecting a downward trend. Year-on-year, there was a -3.43% variation from 2022 to 2023. Over the past five years, the compound annual growth rate (CAGR) was approximately -1.56%, indicating an overall market decline.
Future trends to watch for include potential market stabilization or further decline influenced by healthcare policy changes, antibiotic stewardship programs, and advancements in alternative therapies or antibiotics with improved efficacy and safety profiles.
